Diacylglycerol O-acyltransferase 2α (DGAT2α)
AssigneeThe J. David Gladstone Institutes
InventorsSylvaine Cases, Robert V. Farese, Scot J. Stone, Ping Zhou
Life of this patent
Estimating the term…
Abstract
Nucleic acid compositions encoding mammalian DGAT2α polypeptide products with diglyceride acyltransferase activity, as well as the mammalian DGAT2α polypeptide products encoded thereby and methods for producing the same, are provided. The subject DGAT2α polypeptide and nucleic acid compositions find use in a variety of applications, including research, diagnostic, and therapeutic agent screening applications, as well as in treatment therapies and in the production of triacylglycerols.
Claims2
A method for inhibiting the diacylglycerol O-acyltransferase activity of a diacylglycerol acyltransferase-2α (DGAT2α) protein, said method comprising:
- a) measuring diacylglycerol acyltransferase activity of said DGAT2α protein;
- and
- b) contacting said DGAT2α protein with an antibody that inhibits the diacylglycerol O-acyltransferase activity of said DGAT2α protein, wherein the DGAT2α protein comprises an amino acid sequence having at least about 98% identity to the amino acid sequence set forth in SEQ ID NO:2.
Dependencies are inferred from the claim text.